Unknown

Dataset Information

0

The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation.


ABSTRACT: Macrophage migration inhibitory factor (MIF) is an immunomodulatory protein with a pathogenic activity in various inflammatory disorders, autoimmune diseases, and cancer. The majority of MIF-triggered pathological conditions are associated with activation of the cell surface receptor CD74. In the absence of small molecule antagonists that directly target CD74, MIF variants and MIF-ligand complexes have served as modulators of CD74 activity. These molecules have been reported to have either antagonistic or agonistic effects against the receptor, although the mechanistic parameters that distinguish the two groups are largely unknown. Through molecular dynamics simulations and NMR experiments, we explored the relationship between MIF's catalytically active N-terminus and the surface residues important for the activation of CD74. We found that the two sites are connected via backbone dynamics that are propagated to the CD74 activation surface of MIF, from the β2 and β4 strands. Our results also provide mechanistic evidence that explain the functional characteristics of MIF variants, serving as CD74 agonists or antagonists. Such findings are of high importance for understanding the MIF-induced activation of CD74 as well as for the development of highly potent CD74 therapeutics.

SUBMITTER: Parkins A 

PROVIDER: S-EPMC8511117 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation.

Parkins Andrew A   Skeens Erin E   McCallum C Michael CM   Lisi George P GP   Pantouris Georgios G  

Biophysical journal 20210824 18


Macrophage migration inhibitory factor (MIF) is an immunomodulatory protein with a pathogenic activity in various inflammatory disorders, autoimmune diseases, and cancer. The majority of MIF-triggered pathological conditions are associated with activation of the cell surface receptor CD74. In the absence of small molecule antagonists that directly target CD74, MIF variants and MIF-ligand complexes have served as modulators of CD74 activity. These molecules have been reported to have either antag  ...[more]

Similar Datasets

| S-EPMC3703972 | biostudies-literature
| S-EPMC5248574 | biostudies-literature
| S-EPMC4575896 | biostudies-literature
| S-EPMC6282165 | biostudies-literature
| S-EPMC9022605 | biostudies-literature
| S-EPMC3586206 | biostudies-literature
| S-EPMC11259151 | biostudies-literature
| S-EPMC8405996 | biostudies-literature
| S-EPMC4905490 | biostudies-literature
| S-EPMC3788583 | biostudies-literature